Oncology Information Systems Market by Product & Services (Software and Service), Application (Radiation Oncology, Medical Oncology, and Surgical Oncology), and End User (Hospital & Oncology Clinic and Research Center): Global Opportunity Analysis and Industry Forecast, 2021–2030
The global oncology information systems market was valued at $3,082.3 million in 2020, and is estimated to reach $5,538.66 million by 2030, growing at a CAGR of 6% from 2021 to 2030.
Oncology information system (OIS) is a comprehensive data and image management solution that aids in the management and optimization of cancer patient profiles and treatment. In healthcare settings such as clinics, hospitals, and research laboratories, patient portfolios are managed by software known as OIS. OIS allows the management of patient profiles by combining surgical, radiation, and medical oncology information in one system . Furthermore, these systems aid in the manage & schedule treatment plans of cancer patients and the prediction of treatment outcomes. These systems improve the safety and efficiency of cancer treatment, owing to their ability to predict treatment outcomes.
The major factor driving the growth of the OIS market is the increase in prevalence of cancer cases globally. Surge in cancer incidence and plethora of treatment patterns have compelled healthcare providers to implement a comprehensive data management system for maintaining large data sets, such as patient records and treatment practices. These data management systems, also known as OIS, are intended for proper patient record documentation, patient treatment, pattern maintenance, electronic health record (EHR)/electronic medical record (EMR) maintenance, and treatment prediction.
For instance, in December 2021, RaySearch Laboratories AB announced the release of a new version of RayCare, a next-generation OIS. The ability for users to configure their own workflows and documents is important new feature of RayCare 5B. RayCare 5B provides full user configurability of all workflow configuration settings, including the ability to create advanced workflow automation from the administrator's workspace. Thus, launch of such products with wide range of functionalities contributes to the growth of the market.
In addition, OIS provides complete and precise information on personal & medical histories, clinical diagnoses, actual & planned treatment regimens, and post-treatment outcomes. These systems monitor various modalities of oncology care for patients. Electronic record maintenance is of prime importance, due to negligible possibility of discrepancies or errors resulting due to manual intervention. Furthermore, paper-based medical record systems are known to have major issues due to incomplete data, poor accessibility, inaccuracy, and challenges to patient confidentiality. These are incompetent tools for record-sharing of interdisciplinary patient assessment & management and quality control monitoring to ensure improvement. Hence, the need to gradually switch from paper-based records to electronic records in healthcare management is anticipated to boost the OIS market growth.
However, high costs associated with the OIS systems and dearth of trained workforce for handling such healthcare management and information technology systems are the factors expected to restrain the market growth. Conversely, various strategies among the key players such as partnerships, product launch, collaborations, acquisitions, and increase in use of artificial intelligence are expected to provide lucrative opportunities for the key players to invest in the OIS market.
Moreover, the incorporation of artificial intelligence (AI) in OIS is anticipated to revolutionize cancer treatment and follow-up procedures. The use of AI algorithms with OIS is expected to change the course of cancer treatment with more predefined and thorough analyses, which would benefit patients through a more focused prognosis,contributing toward the market growth.
Furthermore, presence of a plethora of products in the pipeline and high market potential in untapped emerging economies are anticipated to serve as attractive opportunities for market growth during the forecast period. Surge in cancer cases along with rise in cancer awareness by the government and private organizations has opened up new avenues for the cancer treatment.
The OIS market is segmented into product & services, application, end user, and region. On the basis of product & service, it is bifurcated into software and services. The software segment is further divided into patient information systems and treatment planning systems, while the services segment is categorized into consulting/optimization services, implementation services, and maintenance services. By application, it is fragmented into radiation, medical, and surgical oncology. Depending on end user, it is classified into hospitals & oncology clinics, and research centers. Region wise, it is analyzed across North America, Europe, Asia-Pacific, and Latin America, Middle East, and Africa (LAMEA).
The major players profiled in the report are Accuray Incorporated, BMSI Partners Inc., (Bogardus Medical Systems, Inc.), Cerner Corporation, CureMD Corporation, Elekta AB, F. Hoffmann-LA Roche Ag (Flatiron Health, Inc.), Siemens AG (Siemens Healthnieers), Koninklijke Philips N.V., McKesson Corporation, and Nasdaq Inc. (RaySearch Laboratories AB).
KEY BENEFITS FOR STAKEHOLDERS
This report provides an extensive analysis of the current and emerging market trends and dynamics in the global OIS market to identify the prevailing opportunities.
This study presents the competitive landscape of the global market to predict the competitive environment across geographies.
Comprehensive analysis of factors that drive and restrict the market growth are provided.
Region- & country-wise analysis is provided to understand the market trends and dynamics.
KEY MARKET SEGMENTS
By Product & Services
Software
Patient Information Systems
Treatment Planning Systems
Services
Consulting Services
Implementation Services
Maintenance Services
By Application
Radiation Oncology
Medical Oncology
Surgical Oncology
By End User
Hospitals & Oncology Clinics
Research Centers
By Region
North America
U.S.
Canada
Mexico
Europe
UK
Germany
France
Italy
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
Rest of Asia-Pacific
LAMEA
Brazil
South Africa
Turkey
Saudi Arabia
Rest of LAMEA
KEY MARKET PLAYERS
Accuray Incorporated
BMSI Partners Inc., (Bogardus Medical Systems, Inc.)
Cerner Corporation
CureMD Corporation
Elekta AB
F. Hoffmann-LA Roche Ag (Flatiron Health, Inc.)
Siemens AG (Siemens Healthnieers)
Koninklijke Philips N.V.
McKesson Corporation
Nasdaq Inc. (RaySearch Laboratories AB)
- CHAPTER 1:INTRODUCTION
- 1.1.Report Description
- 1.2.Key Market Segments
- 1.3.Key Benefits
- 1.4.Research Methodology
- 1.4.1.Primary Research
- 1.4.2.Secondary Research
- 1.4.3.Analyst Tools and Models
- CHAPTER 2:EXECUTIVE SUMMARY
- 2.1.CXO Perspective
- CHAPTER 3:MARKET LANDSCAPE
- 3.1.Market Definition and Scope
- 3.2.Key Findings
- 3.2.1.Top Investment Pockets
- 3.2.2.Top Winning Strategies
- 3.3.Porter's Five Forces Analysis
- 3.3.1.Bargaining Power of Suppliers
- 3.3.2.Threat of New Entrants
- 3.3.3.Threat of Substitutes
- 3.3.4.Competitive Rivalry
- 3.3.5.Bargaining Power among Buyers
- 3.4.Market Share Analysis/Top Player Positioning
- 3.4.1.Market Share Analysis/Top Player Positioning 2020
- 3.5.Market Dynamics
- 3.5.1.Drivers
- 3.5.2.Restraints
- 3.5.3.Opportunities
- 3.6.COVID-19 Impact Analysis
- CHAPTER 4:ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT AND SERVICES
- 4.1.Market Overview
- 4.1.1Market Size and Forecast, By Product And Services
- 4.2.Software
- 4.2.1.Key Market Trends, Growth Factors and Opportunities
- 4.2.2.Market Size and Forecast, By Region
- 4.2.3.Market Share Analysis, By Country
- 4.2.4.Patient Information Systems
- 4.2.4.1.Market Size and Forecast
- 4.2.5.Treatment Planning Systems
- 4.2.5.1.Market Size and Forecast
- 4.3.Services
- 4.3.1.Key Market Trends, Growth Factors and Opportunities
- 4.3.2.Market Size and Forecast, By Region
- 4.3.3.Market Share Analysis, By Country
- 4.3.4.Consulting Services
- 4.3.4.1.Market Size and Forecast
- 4.3.5.Implementation Services
- 4.3.5.1.Market Size and Forecast
- 4.3.6.Maintenance Services
- 4.3.6.1.Market Size and Forecast
- CHAPTER 5:ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION
- 5.1.Market Overview
- 5.1.1Market Size and Forecast, By Application
- 5.2.Radiation Oncology
- 5.2.1.Market Size and Forecast, By Region
- 5.2.2.Market Share Analysis, By Country
- 5.3.Medical Oncology
- 5.3.1.Market Size and Forecast, By Region
- 5.3.2.Market Share Analysis, By Country
- 5.4.Surgical Oncology
- 5.4.1.Market Size and Forecast, By Region
- 5.4.2.Market Share Analysis, By Country
- CHAPTER 6:ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER
- 6.1.Market Overview
- 6.1.1Market Size and Forecast, By End User
- 6.2.Hospitals and Oncology Clinics
- 6.2.1.Market Size and Forecast, By Region
- 6.2.2.Market Share Analysis, By Country
- 6.3.Research Centers
- 6.3.1.Market Size and Forecast, By Region
- 6.3.2.Market Share Analysis, By Country
- CHAPTER 7:ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION
- 7.1.Market Overview
- 7.1.1Market Size and Forecast, By Region
- 7.2.North America
- 7.2.1.Key Market Trends and Opportunities
- 7.2.2.Market Size and Forecast, By Product and Services
- 7.2.3.Market Size and Forecast, By Application
- 7.2.4.Market Size and Forecast, By End User
- 7.2.5.Market Size and Forecast, By Country
- 7.2.6.United States Oncology Information Systems Market
- 7.2.6.1.Market Size and Forecast, By Product and Services
- 7.2.6.2.Market Size and Forecast, By Application
- 7.2.6.3.Market Size and Forecast, By End User
- 7.2.7.Canada Oncology Information Systems Market
- 7.2.7.1.Market Size and Forecast, By Product and Services
- 7.2.7.2.Market Size and Forecast, By Application
- 7.2.7.3.Market Size and Forecast, By End User
- 7.2.8.Mexico Oncology Information Systems Market
- 7.2.8.1.Market Size and Forecast, By Product and Services
- 7.2.8.2.Market Size and Forecast, By Application
- 7.2.8.3.Market Size and Forecast, By End User
- 7.3.Europe
- 7.3.1.Key Market Trends and Opportunities
- 7.3.2.Market Size and Forecast, By Product and Services
- 7.3.3.Market Size and Forecast, By Application
- 7.3.4.Market Size and Forecast, By End User
- 7.3.5.Market Size and Forecast, By Country
- 7.3.6.France Oncology Information Systems Market
- 7.3.6.1.Market Size and Forecast, By Product and Services
- 7.3.6.2.Market Size and Forecast, By Application
- 7.3.6.3.Market Size and Forecast, By End User
- 7.3.7.Germany Oncology Information Systems Market
- 7.3.7.1.Market Size and Forecast, By Product and Services
- 7.3.7.2.Market Size and Forecast, By Application
- 7.3.7.3.Market Size and Forecast, By End User
- 7.3.8.Italy Oncology Information Systems Market
- 7.3.8.1.Market Size and Forecast, By Product and Services
- 7.3.8.2.Market Size and Forecast, By Application
- 7.3.8.3.Market Size and Forecast, By End User
- 7.3.9.U.K Oncology Information Systems Market
- 7.3.9.1.Market Size and Forecast, By Product and Services
- 7.3.9.2.Market Size and Forecast, By Application
- 7.3.9.3.Market Size and Forecast, By End User
- 7.3.10.Rest Of Europe Oncology Information Systems Market
- 7.3.10.1.Market Size and Forecast, By Product and Services
- 7.3.10.2.Market Size and Forecast, By Application
- 7.3.10.3.Market Size and Forecast, By End User
- 7.4.Asia-Pacific
- 7.4.1.Key Market Trends and Opportunities
- 7.4.2.Market Size and Forecast, By Product and Services
- 7.4.3.Market Size and Forecast, By Application
- 7.4.4.Market Size and Forecast, By End User
- 7.4.5.Market Size and Forecast, By Country
- 7.4.6.China Oncology Information Systems Market
- 7.4.6.1.Market Size and Forecast, By Product and Services
- 7.4.6.2.Market Size and Forecast, By Application
- 7.4.6.3.Market Size and Forecast, By End User
- 7.4.7.Japan Oncology Information Systems Market
- 7.4.7.1.Market Size and Forecast, By Product and Services
- 7.4.7.2.Market Size and Forecast, By Application
- 7.4.7.3.Market Size and Forecast, By End User
- 7.4.8.India Oncology Information Systems Market
- 7.4.8.1.Market Size and Forecast, By Product and Services
- 7.4.8.2.Market Size and Forecast, By Application
- 7.4.8.3.Market Size and Forecast, By End User
- 7.4.9.Australia Oncology Information Systems Market
- 7.4.9.1.Market Size and Forecast, By Product and Services
- 7.4.9.2.Market Size and Forecast, By Application
- 7.4.9.3.Market Size and Forecast, By End User
- 7.4.10.Rest of Asia Pacific Oncology Information Systems Market
- 7.4.10.1.Market Size and Forecast, By Product and Services
- 7.4.10.2.Market Size and Forecast, By Application
- 7.4.10.3.Market Size and Forecast, By End User
- 7.5.LAMEA
- 7.5.1.Key Market Trends and Opportunities
- 7.5.2.Market Size and Forecast, By Product and Services
- 7.5.3.Market Size and Forecast, By Application
- 7.5.4.Market Size and Forecast, By End User
- 7.5.5.Market Size and Forecast, By Country
- 7.5.6.Brazil Oncology Information Systems Market
- 7.5.6.1.Market Size and Forecast, By Product and Services
- 7.5.6.2.Market Size and Forecast, By Application
- 7.5.6.3.Market Size and Forecast, By End User
- 7.5.7.South Africa, Oncology Information Systems Market
- 7.5.7.1.Market Size and Forecast, By Product and Services
- 7.5.7.2.Market Size and Forecast, By Application
- 7.5.7.3.Market Size and Forecast, By End User
- 7.5.8.Saudi Arabia Oncology Information Systems Market
- 7.5.8.1.Market Size and Forecast, By Product and Services
- 7.5.8.2.Market Size and Forecast, By Application
- 7.5.8.3.Market Size and Forecast, By End User
- 7.5.9.Turkey Oncology Information Systems Market
- 7.5.9.1.Market Size and Forecast, By Product and Services
- 7.5.9.2.Market Size and Forecast, By Application
- 7.5.9.3.Market Size and Forecast, By End User
- 7.5.10.Rest of LAMEA Oncology Information Systems Market
- 7.5.10.1.Market Size and Forecast, By Product and Services
- 7.5.10.2.Market Size and Forecast, By Application
- 7.5.10.3.Market Size and Forecast, By End User
- CHAPTER 8:COMPANY PROFILES
- 8.1.Accuray Incorporated
- 8.1.1.Company Overview
- 8.1.2.Key Executives
- 8.1.3.Company snapshot
- 8.1.4.Operating business segments
- 8.1.5.Product portfolio
- 8.1.6.Business Performance
- 8.1.7.Key Strategic Moves and Developments
- 8.2.BMSI Partners Inc., (Bogardus Medical Systems, Inc.)
- 8.2.1.Company Overview
- 8.2.2.Key Executives
- 8.2.3.Company snapshot
- 8.2.4.Operating business segments
- 8.2.5.Product portfolio
- 8.3.Cerner Corporation
- 8.3.1.Company Overview
- 8.3.2.Key Executives
- 8.3.3.Company snapshot
- 8.3.4.Operating business segments
- 8.3.5.Product portfolio
- 8.3.6.Business Performance
- 8.3.7.Key Strategic Moves and Developments
- 8.4.CureMD Corporation
- 8.4.1.Company Overview
- 8.4.2.Key Executives
- 8.4.3.Company snapshot
- 8.4.4.Operating business segments
- 8.4.5.Product portfolio
- 8.4.6.Key Strategic Moves and Developments
- 8.5.Elekta AB
- 8.5.1.Company Overview
- 8.5.2.Key Executives
- 8.5.3.Company snapshot
- 8.5.4.Operating business segments
- 8.5.5.Product portfolio
- 8.5.6.Business Performance
- 8.5.7.Key Strategic Moves and Developments
- 8.6.F. Hoffmann LA Roche AG (Flatiron Health, Inc.)
- 8.6.1.Company Overview
- 8.6.2.Key Executives
- 8.6.3.Company snapshot
- 8.6.4.Operating business segments
- 8.6.5.Product portfolio
- 8.6.6.Business Performance
- 8.6.7.Key Strategic Moves and Developments
- 8.7.Siemens AG (Siemens Healthnieers)
- 8.7.1.Company Overview
- 8.7.2.Key Executives
- 8.7.3.Company snapshot
- 8.7.4.Operating business segments
- 8.7.5.Product portfolio
- 8.7.6.Business Performance
- 8.7.7.Key Strategic Moves and Developments
- 8.8.Koninklijke Philips N.V.
- 8.8.1.Company Overview
- 8.8.2.Key Executives
- 8.8.3.Company snapshot
- 8.8.4.Operating business segments
- 8.8.5.Product portfolio
- 8.8.6.Business Performance
- 8.8.7.Key Strategic Moves and Developments
- 8.9.McKesson Corporation
- 8.9.1.Company Overview
- 8.9.2.Key Executives
- 8.9.3.Company snapshot
- 8.9.4.Operating business segments
- 8.9.5.Product portfolio
- 8.9.6.Business Performance
- 8.9.7.Key Strategic Moves and Developments
- 8.10.Nasdaq Inc. (RaySearch Laboratories AB)
- 8.10.1.Company Overview
- 8.10.2.Key Executives
- 8.10.3.Company snapshot
- 8.10.4.Operating business segments
- 8.10.5.Product portfolio
- 8.10.6.Business Performance
- 8.10.7.Key Strategic Moves and Developments
- LIST OF TABLES
- TABLE 1.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 2.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET FOR SOFTWARE, BY REGION, 2020-2030 ($MILLION)
- TABLE 3.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET FOR SERVICES, BY REGION, 2020-2030 ($MILLION)
- TABLE 4.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 5.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET FOR RADIATION ONCOLOGY, BY REGION, 2020-2030 ($MILLION)
- TABLE 6.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET FOR MEDICAL ONCOLOGY, BY REGION, 2020-2030 ($MILLION)
- TABLE 7.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET FOR SURGICAL ONCOLOGY, BY REGION, 2020-2030 ($MILLION)
- TABLE 8.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET, BY END USER, 2020-2030 ($MILLION)
- TABLE 9.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET FOR HOSPITALS AND ONCOLOGY CLINICS, BY REGION, 2020-2030 ($MILLION)
- TABLE 10.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET FOR RESEARCH CENTERS, BY REGION, 2020-2030 ($MILLION)
- TABLE 11.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET, BY REGION, 2020-2030 ($MILLION)
- TABLE 12.NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 13.NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 14.NORTH AMERICA ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 15.UNITED STATES ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 16.UNITED STATES ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 17.UNITED STATES ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 18.CANADA ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 19.CANADA ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 20.CANADA ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 21.MEXICO ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 22.MEXICO ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 23.MEXICO ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 24.EUROPE ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 25.EUROPE ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 26.EUROPE ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 27.FRANCE ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 28.FRANCE ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 29.FRANCE ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 30.GERMANY ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 31.GERMANY ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 32.GERMANY ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 33.ITALY ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 34.ITALY ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 35.ITALY ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 36.UNITED KINGDOM ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 37.UNITED KINGDOM ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 38.UNITED KINGDOM ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 39.REST OF EUROPE ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 40.REST OF EUROPE ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 41.REST OF EUROPE ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 42.ASIA-PACIFIC ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 43.ASIA-PACIFIC ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 44.ASIA-PACIFIC ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 45.CHINA ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 46.CHINA ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 47.CHINA ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 48.JAPAN ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 49.JAPAN ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 50.JAPAN ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 51.INDIA ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 52.INDIA ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 53.INDIA ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 54.AUSTRALIA ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 55.AUSTRALIA ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 56.AUSTRALIA ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 57.REST OF ASIA PACIFIC ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 58.REST OF ASIA PACIFIC ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 59.REST OF ASIA PACIFIC ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 60.LAMEA ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 61.LAMEA ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 62.LAMEA ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 63.BRAZIL ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 64.BRAZIL ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 65.BRAZIL ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 66.SOUTH AFRICA, ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 67.SOUTH AFRICA, ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 68.SOUTH AFRICA, ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 69.SAUDI ARABIA ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 70.SAUDI ARABIA ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 71.SAUDI ARABIA ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 72.TURKEY ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 73.TURKEY ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 74.TURKEY ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 75.REST OF LAMEA ONCOLOGY INFORMATION SYSTEMS, BY PRODUCT AND SERVICES, 2020-2030 ($MILLION)
- TABLE 76.REST OF LAMEA ONCOLOGY INFORMATION SYSTEMS, BY APPLICATION, 2020-2030 ($MILLION)
- TABLE 77.REST OF LAMEA ONCOLOGY INFORMATION SYSTEMS, BY END USER, 2020-2030 ($MILLION)
- TABLE 78.ACCURAY INCORPORATED: KEY EXECUTIVES
- TABLE 79.ACCURAY INCORPORATED: COMPANY SNAPSHOT
- TABLE 80.ACCURAY INCORPORATED: OPERATING SEGMENTS
- TABLE 81.ACCURAY INCORPORATED: PRODUCT PORTFOLIO
- TABLE 82.ACCURAY INCORPORATED: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 83.BMSI PARTNERS INC., (BOGARDUS MEDICAL SYSTEMS, INC.): KEY EXECUTIVES
- TABLE 84.BMSI PARTNERS INC., (BOGARDUS MEDICAL SYSTEMS, INC.): COMPANY SNAPSHOT
- TABLE 85.BMSI PARTNERS INC., (BOGARDUS MEDICAL SYSTEMS, INC.): OPERATING SEGMENTS
- TABLE 86.BMSI PARTNERS INC., (BOGARDUS MEDICAL SYSTEMS, INC.): PRODUCT PORTFOLIO
- TABLE 87.CERNER CORPORATION: KEY EXECUTIVES
- TABLE 88.CERNER CORPORATION: COMPANY SNAPSHOT
- TABLE 89.CERNER CORPORATION: OPERATING SEGMENTS
- TABLE 90.CERNER CORPORATION: PRODUCT PORTFOLIO
- TABLE 91.CERNER CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 92.CUREMD CORPORATION: KEY EXECUTIVES
- TABLE 93.CUREMD CORPORATION: COMPANY SNAPSHOT
- TABLE 94.CUREMD CORPORATION: OPERATING SEGMENTS
- TABLE 95.CUREMD CORPORATION: PRODUCT PORTFOLIO
- TABLE 96.CUREMD CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 97.ELEKTA AB: KEY EXECUTIVES
- TABLE 98.ELEKTA AB: COMPANY SNAPSHOT
- TABLE 99.ELEKTA AB: OPERATING SEGMENTS
- TABLE 100.ELEKTA AB: PRODUCT PORTFOLIO
- TABLE 101.ELEKTA AB: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 102.F. HOFFMANN LA ROCHE AG (FLATIRON HEALTH, INC.): KEY EXECUTIVES
- TABLE 103.F. HOFFMANN LA ROCHE AG (FLATIRON HEALTH, INC.): COMPANY SNAPSHOT
- TABLE 104.F. HOFFMANN LA ROCHE AG (FLATIRON HEALTH, INC.): OPERATING SEGMENTS
- TABLE 105.F. HOFFMANN LA ROCHE AG (FLATIRON HEALTH, INC.): PRODUCT PORTFOLIO
- TABLE 106.F. HOFFMANN LA ROCHE AG (FLATIRON HEALTH, INC.): KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 107.SIEMENS AG (SIEMENS HEALTHNIEERS): KEY EXECUTIVES
- TABLE 108.SIEMENS AG (SIEMENS HEALTHNIEERS): COMPANY SNAPSHOT
- TABLE 109.SIEMENS AG (SIEMENS HEALTHNIEERS): OPERATING SEGMENTS
- TABLE 110.SIEMENS AG (SIEMENS HEALTHNIEERS): PRODUCT PORTFOLIO
- TABLE 111.SIEMENS AG (SIEMENS HEALTHNIEERS): KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 112.KONINKLIJKE PHILIPS N.V.: KEY EXECUTIVES
- TABLE 113.KONINKLIJKE PHILIPS N.V.: COMPANY SNAPSHOT
- TABLE 114.KONINKLIJKE PHILIPS N.V.: OPERATING SEGMENTS
- TABLE 115.KONINKLIJKE PHILIPS N.V.: PRODUCT PORTFOLIO
- TABLE 116.KONINKLIJKE PHILIPS N.V.: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 117.MCKESSON CORPORATION: KEY EXECUTIVES
- TABLE 118.MCKESSON CORPORATION: COMPANY SNAPSHOT
- TABLE 119.MCKESSON CORPORATION: OPERATING SEGMENTS
- TABLE 120.MCKESSON CORPORATION: PRODUCT PORTFOLIO
- TABLE 121.MCKESSON CORPORATION: KEY STRATEGIC MOVES AND DEVELOPMENTS
- TABLE 122.NASDAQ INC. (RAYSEARCH LABORATORIES AB): KEY EXECUTIVES
- TABLE 123.NASDAQ INC. (RAYSEARCH LABORATORIES AB): COMPANY SNAPSHOT
- TABLE 124.NASDAQ INC. (RAYSEARCH LABORATORIES AB): OPERATING SEGMENTS
- TABLE 125.NASDAQ INC. (RAYSEARCH LABORATORIES AB): PRODUCT PORTFOLIO
- TABLE 126.NASDAQ INC. (RAYSEARCH LABORATORIES AB): KEY STRATEGIC MOVES AND DEVELOPMENTS
- LIST OF FIGURES
- FIGURE 1.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET SEGMENTATION
- FIGURE 2.GLOBAL ONCOLOGY INFORMATION SYSTEMS MARKET
- FIGURE 3.SEGMENTATION ONCOLOGY INFORMATION SYSTEMS MARKET
- FIGURE 4.TOP INVESTMENT POCKET IN ONCOLOGY INFORMATION SYSTEMS MARKET
- FIGURE 5.TOP WINNING STRATEGIES, 2019-2021*
- FIGURE 6.TOP WINNING STRATEGIES, BY DEVELOPMENT, 2019-2021(%)
- FIGURE 7.TOP WINNING STRATEGIES, BY COMPANY, 2019-2021*
- FIGURE 8.MODERATE BARGAINING POWER OF BUYERS
- FIGURE 9.MODERATE BARGAINING POWER OF SUPPLIERS
- FIGURE 10.MODERATE THREAT OF NEW ENTRANTS
- FIGURE 11.LOW THREAT OF SUBSTITUTION
- FIGURE 12.HIGH COMPETITIVE RIVALRY
- FIGURE 13.TOP PLAYER POSITIONING, 2020
- FIGURE 14.MARKET SHARE ANALYSIS, 2020
- FIGURE 15.RESTRAINTS AND DRIVERS: ONCOLOGY INFORMATION SYSTEMS MARKET
- FIGURE 16.ONCOLOGY INFORMATION SYSTEMS MARKET SEGMENTATION, BY PRODUCT AND SERVICES
- FIGURE 17.ONCOLOGY INFORMATION SYSTEMS MARKET FOR SOFTWARE, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 18.ONCOLOGY INFORMATION SYSTEMS MARKET FOR SERVICES, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 19.ONCOLOGY INFORMATION SYSTEMS MARKET SEGMENTATION, BY APPLICATION
- FIGURE 20.ONCOLOGY INFORMATION SYSTEMS MARKET FOR RADIATION ONCOLOGY, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 21.ONCOLOGY INFORMATION SYSTEMS MARKET FOR MEDICAL ONCOLOGY, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 22.ONCOLOGY INFORMATION SYSTEMS MARKET FOR SURGICAL ONCOLOGY, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 23.ONCOLOGY INFORMATION SYSTEMS MARKET SEGMENTATION, BY END USER
- FIGURE 24.ONCOLOGY INFORMATION SYSTEMS MARKET FOR HOSPITALS AND ONCOLOGY CLINICS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 25.ONCOLOGY INFORMATION SYSTEMS MARKET FOR RESEARCH CENTERS, BY COUNTRY, 2020-2030 ($MILLION)
- FIGURE 26.ACCURAY INCORPORATED: NET SALES, 2018-2020 ($MILLION)
- FIGURE 27.ACCURAY INCORPORATED: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 28.ACCURAY INCORPORATED: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 29.CERNER CORPORATION: NET SALES, 2018-2020 ($MILLION)
- FIGURE 30.CERNER CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 31.CERNER CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 32.ELEKTA AB: NET SALES, 2018-2020 ($MILLION)
- FIGURE 33.ELEKTA AB: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 34.ELEKTA AB: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 35.F. HOFFMANN LA ROCHE AG (FLATIRON HEALTH, INC.): NET SALES, 2018-2020 ($MILLION)
- FIGURE 36.F. HOFFMANN LA ROCHE AG (FLATIRON HEALTH, INC.): REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 37.F. HOFFMANN LA ROCHE AG (FLATIRON HEALTH, INC.): REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 38.SIEMENS AG (SIEMENS HEALTHNIEERS): NET SALES, 2018-2020 ($MILLION)
- FIGURE 39.SIEMENS AG (SIEMENS HEALTHNIEERS): REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 40.SIEMENS AG (SIEMENS HEALTHNIEERS): REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 41.KONINKLIJKE PHILIPS N.V.: NET SALES, 2018-2020 ($MILLION)
- FIGURE 42.KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 43.KONINKLIJKE PHILIPS N.V.: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 44.MCKESSON CORPORATION: NET SALES, 2018-2020 ($MILLION)
- FIGURE 45.MCKESSON CORPORATION: REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 46.MCKESSON CORPORATION: REVENUE SHARE, BY REGION, 2020 (%)
- FIGURE 47.NASDAQ INC. (RAYSEARCH LABORATORIES AB): NET SALES, 2018-2020 ($MILLION)
- FIGURE 48.NASDAQ INC. (RAYSEARCH LABORATORIES AB): REVENUE SHARE, BY SEGMENT, 2020 (%)
- FIGURE 49.NASDAQ INC. (RAYSEARCH LABORATORIES AB): REVENUE SHARE, BY REGION, 2020 (%)
Research Assistance
Learn how to effectively navigate the market research process to help guide your organization on the journey to success.
Download eBook